The article highlights the continuous improvement of China's legislative and regulatory framework for biosecurity amidst the rapid development of biological products,particularly following the enforcement of the"Biosafety Law of the People's Republic of China,"which has bolstered biosafety management.It explores the establishment of a biosecurity defense line in the regulation of biological products in China,examining the requirements for biosafety management,challenges faced,and strategies for preventive control.Utilizing regulatory analysis and literature research,the article identifies risk factors in biosafety management of biological products and suggests corresponding management strategies.It emphasizes the importance of defining the primary responsibilities of relevant entities in biological product development,strengthening management of crucial research and production stages,and establishing collaborative regulatory mechanisms between oversight agencies to enhance biosafety management.The article concludes with recommendations to enhance legislation and regulations,improve education and training,and bolster regulatory capacities to advance biosafety management in China's biological products,ensuring product quality and safety,as well as safeguarding public health.
维普
万方数据